These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36110921)

  • 1. Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.
    Lei WS; Kilberg MJ; Zemel BS; Rubenstein RC; Harris C; Sheikh S; Kelly A; Kindler JM
    J Clin Transl Endocrinol; 2022 Dec; 30():100304. PubMed ID: 36110921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone resorption and incretin hormones following glucose ingestion in healthy emerging adults.
    Lei WS; Rodrick EB; Belcher SL; Kelly A; Kindler JM
    J Clin Transl Endocrinol; 2023 Mar; 31():100314. PubMed ID: 36845829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
    Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
    Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
    Bergmann NC; Lund A; Gasbjerg LS; Jørgensen NR; Jessen L; Hartmann B; Holst JJ; Christensen MB; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2953-2960. PubMed ID: 30848791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endogenous GIP and GLP-1 in postprandial bone homeostasis.
    Helsted MM; Gasbjerg LS; Lanng AR; Bergmann NC; Stensen S; Hartmann B; Christensen MB; Holst JJ; Vilsbøll T; Rosenkilde MM; Knop FK
    Bone; 2020 Nov; 140():115553. PubMed ID: 32730920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis.
    Nyirjesy SC; Peleckis AJ; Eiel JN; Gallagher K; Doliba A; Tami A; Flatt AJ; De Leon DD; Hadjiliadis D; Sheikh S; Stefanovski D; Gallop R; D'Alessio DA; Rubenstein RC; Kelly A; Rickels MR
    Diabetes; 2022 Oct; 71(10):2153-2165. PubMed ID: 35796669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.
    Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hartmann B; Holst JJ; Hermansen K; Gregersen S; Starup-Linde J
    Bone; 2020 Apr; 133():115230. PubMed ID: 31954199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study.
    Skov-Jeppesen K; Veedfald S; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    Bone; 2021 Nov; 152():116065. PubMed ID: 34153529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
    Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.
    Skov-Jeppesen K; Christiansen CB; Hansen LS; Windeløv JA; Hedbäck N; Gasbjerg LS; Hindsø M; Svane MS; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1773-1780. PubMed ID: 38217866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
    Kelly A; Sheikh S; Stefanovski D; Peleckis AJ; Nyirjesy SC; Eiel JN; Sidhaye A; Localio R; Gallop R; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2617-2634. PubMed ID: 34406395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.
    Skov-Jeppesen K; Svane MS; Martinussen C; Gabe MBN; Gasbjerg LS; Veedfald S; Bojsen-Møller KN; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    Bone; 2019 Aug; 125():178-185. PubMed ID: 31100534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
    Aitken ML; Szkudlinska MA; Boyko EJ; Ng D; Utzschneider KM; Kahn SE
    Diabetologia; 2020 May; 63(5):1055-1065. PubMed ID: 31993716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
    Nauck MA; Quast DR; Wefers J; Pfeiffer AFH
    Diabetes Obes Metab; 2021 Sep; 23 Suppl 3():5-29. PubMed ID: 34310013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut-Bone Axis in Diabetes.
    Maagensen H; Helsted MM; Gasbjerg LS; Vilsbøll T; Knop FK
    Curr Osteoporos Rep; 2023 Feb; 21(1):21-31. PubMed ID: 36441432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin.
    Sun X; Yi Y; Liang B; Yang Y; He N; Ode KL; Uc A; Wang K; Gibson-Corley KN; Engelhardt JF; Norris AW
    J Cyst Fibros; 2019 Jul; 18(4):557-565. PubMed ID: 30738804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
    Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta cell function, incretin hormones, and incretin effect in obese children and adolescents with prediabetes.
    Sakornyutthadej N; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Khlairit P; Poomthavorn P
    Pediatr Diabetes; 2022 Mar; 23(2):203-211. PubMed ID: 34913553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.